Linus Biotechnology Inc. — Form D
Linus Biotechnology Inc. of North Brunswick, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2024-08-12. The offering totals $10.0M, of which $6.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-08-12
- Form: D
- Accession: 0001918153-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $6.1M
- Remaining: $3.9M
- Investors: 4
- Date of first sale: 2024-07-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-521234
Issuer
- Name: Linus Biotechnology Inc.
- CIK: 0001918153
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 675 US 1, North Brunswick, NJ, 08902
- Phone: 917-373-9740
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| MANISH ARORA | Director | NEW YORK, NY |
| Amol Deshpande | Director | Waltham, MA |
| Ashok Krishnamurthi | Director | San Francisco, CA |
| Rafi Syed | Director | North Brunswick, NJ |
| MANISH ARORA | Executive Officer | NEW YORK, NY |
| Jan Glassner | Director | New Rochelle, NY |
| Jan Glassner | Executive Officer | New Rochelle, NY |
Other filings by this issuer (2)
More